Skip to content

Clinical trials

Phase 2 Skin Diseases, Infectious trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Skin Diseases, Infectious Phase: Phase 2 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20081
20101
20182
20191
20201
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting1
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Verrica Pharmaceuticals Inc.2
Drugs for Neglected Diseases1
Furiex Pharmaceuticals, Inc1
Laboratoire Boreaderme Inc.1
Melinta Therapeutics, Inc.1
Merck Sharp & Dohme LLC1
Paratek Pharmaceuticals Inc1
Shenzhen Shenxin Biotechnology Co., Ltd1
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Wyeth is now a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Skin Diseases, Infectious11
Skin Diseases5
Skin Diseases, Bacterial4
Infections3
Skin Diseases, Viral3
Virus Diseases3
Abscess2
Bacterial Infections2
DNA Virus Infections2
Herpesviridae Infections2

Trials

Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.